New pill aims to keep depression away longer

NCT ID NCT07196501

First seen Oct 01, 2025 · Last updated May 12, 2026 · Updated 27 times

Summary

This study tests whether an experimental drug called NBI-1065845 can help people with major depression stay well longer when added to their usual antidepressant. About 550 adults who haven't fully responded to current antidepressants will receive either the study drug or a placebo. The main goal is to see if the drug delays the return of depressive symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Neurocrine Clinical Site

    RECRUITING

    Oceanside, California, 92056, United States

  • Neurocrine Clinical Site

    RECRUITING

    San Jose, California, 95124, United States

  • Neurocrine Clinical Site

    RECRUITING

    New Haven, Connecticut, 06520, United States

  • Neurocrine Clinical Site

    RECRUITING

    Miami Gardens, Florida, 33014, United States

  • Neurocrine Clinical Site

    RECRUITING

    Orlando, Florida, 32803, United States

  • Neurocrine Clinical Site

    RECRUITING

    Palm Bay, Florida, 32905, United States

  • Neurocrine Clinical Site

    RECRUITING

    Tampa, Florida, 33629, United States

  • Neurocrine Clinical Site

    RECRUITING

    Marrero, Louisiana, 70072, United States

  • Neurocrine Clinical Site

    RECRUITING

    O'Fallon, Missouri, 63368, United States

  • Neurocrine Clinical Site

    RECRUITING

    Albuquerque, New Mexico, 87109, United States

  • Neurocrine Clinical Site

    RECRUITING

    Charlotte, North Carolina, 28211, United States

  • Neurocrine Clinical Site

    RECRUITING

    Edmond, Oklahoma, 73013, United States

  • Neurocrine Clinical Site

    RECRUITING

    Oklahoma City, Oklahoma, 73112, United States

  • Neurocrine Clinical Site

    RECRUITING

    Bellaire, Texas, 77401, United States

  • Neurocrine Clinical Site

    RECRUITING

    Friendswood, Texas, 77546, United States

  • Neurocrine Clinical Site

    RECRUITING

    Stafford, Texas, 77477, United States

  • Neurocrine Clinical Site

    RECRUITING

    Wichita Falls, Texas, 76309, United States

  • Neurocrine Clinical Site

    RECRUITING

    Draper, Utah, 84020, United States

  • Neurocrine Clinical Site

    RECRUITING

    Carlton, Victoria, 3053, Australia

  • Neurocrine Clinical Site

    RECRUITING

    Sofia, 1303, Bulgaria

  • Neurocrine Clinical Site

    RECRUITING

    Sofia, 1408, Bulgaria

  • Neurocrine Clinical Site

    RECRUITING

    Sofia, 1510, Bulgaria

  • Neurocrine Clinical Site

    RECRUITING

    Sofia, 1680, Bulgaria

  • Neurocrine Clinical Site

    RECRUITING

    North Vancouver, British Columbia, V7P 2T4, Canada

  • Neurocrine Clinical Site

    RECRUITING

    Sherbrooke, Quebec, J1L 0H8, Canada

  • Neurocrine Clinical Site

    RECRUITING

    Toronto, M5H 1A1, Canada

  • Neurocrine Clinical Site

    RECRUITING

    Tallinn, 10138, Estonia

  • Neurocrine Clinical Site

    RECRUITING

    Tallinn, 11315, Estonia

  • Neurocrine Clinical Site

    RECRUITING

    Tartu, 50417, Estonia

  • Neurocrine Clinical Site

    RECRUITING

    Milan, 20127, Italy

  • Neurocrine Clinical Site

    RECRUITING

    Rome, 168, Italy

  • Neurocrine Clinical Site

    RECRUITING

    Bialystok, 15-879, Poland

  • Neurocrine Clinical Site

    RECRUITING

    Bydgoszcz, 85-794, Poland

  • Neurocrine Clinical Site

    RECRUITING

    Gdansk, 80-283, Poland

  • Neurocrine Clinical Site

    RECRUITING

    Belgrade, 11000, Serbia

  • Neurocrine Clinical Site

    RECRUITING

    Kovin, 26220, Serbia

  • Neurocrine Clinical Site

    RECRUITING

    Ansan-si, Gyeonggi-do, 15355, South Korea

  • Neurocrine Clinical Site

    RECRUITING

    Seoul, 02841, South Korea

  • Neurocrine Clinical Site

    RECRUITING

    Seoul, 06351, South Korea

  • Neurocrine Clinical Site

    RECRUITING

    Alcorcón, Madrid, 28922, Spain

  • Neurocrine Clinical Site

    RECRUITING

    Barcelona, 08035, Spain

  • Neurocrine Clinical Site

    RECRUITING

    Keelung, 204, Taiwan

  • Neurocrine Clinical Site

    RECRUITING

    Taipei, 10449, Taiwan

  • Neurocrine Clinical Site

    RECRUITING

    Taipei, 110, Taiwan

  • Neurocrine Clinical Site

    RECRUITING

    Taipei, 11217, Taiwan

Conditions

Explore the condition pages connected to this study.